Despite becoming the leading market in the U.S. in 2023, Michigan’s cannabis industry faces a complex landscape marked by declining prices, corporate struggles, and potential federal regulatory changes.
Sales in Michigan soared to $2.8 billion through November 2023, outperforming older markets like California and Colorado. This growth is expected to push the total sales beyond $3 billion by year’s end.
Price Plunges And Obstacles To Profitability
This growth, however, unfolded amid a dramatic price collapse. The average cost of an ounce of marijuana plummeted to $80.16 in January 2023, a steep decline from over $500 in 2020. The year also witnessed the court-ordered receivership of Skymint, Michigan’s largest marijuana grower, indicating the challenges of non-traditional financing and volatile business models within the industry, noted Crain’s Detroit.
Tax Success, Corruption Scandals And Potential Regulatory Revolution in 2024
Despite these hurdles, the industry’s maturation was evident. Marijuana excise taxes surpassed combined taxes from beer, wine and alcohol sales, despite the state’s low taxation on cannabis. Yet, the year was tainted by corruption, leading to charges and jail sentences for lobbyists and former Michigan House Speaker Rick Johnson.
Looking ahead to 2024, the U.S. Department of Health and Human Services’ recommendation to the DEA to reschedule cannabis could revolutionize the industry. This change would alleviate banking restrictions, reduce tax burdens under tax code 280E, and enhance cash flow for businesses.
Approaching Market Saturation Amid Decline Of Medical Marijuana Sector
However, Michigan’s market might be nearing its zenith. With 2023 sales peaking in July and showing a subsequent decline, experts predict the market’s ceiling to be around $3.2 billion.
The medical marijuana sector, once a cornerstone of the state’s legal cannabis industry, is also diminishing. November 2023 saw medical sales drop to a mere 2.8% of total marijuana sales. The stringent regulations differentiating medical and adult-use dispensaries are pushing operators away from maintaining medical licenses.
To read more, click on Benzinga